To determine the potential biological effects of HA-CH-NP/mPLXDC1 siRNA treatment in tumor tissues, we stained the tumors for markers of PLXDC1, cell proliferation (Ki67), microvessel density (MVD, CD31), and apoptosis (TUNEL). The gene discussed is PLXDC1; the disease is neoplasm.